Financhill
Back

Editas Medicine Quote, Financials, Valuation and Earnings

Editas Medicine Price Quote

$5.68
+0.06 (+1.07%)
(Updated: May 3, 2024 at 2:50 PM ET)

Editas Medicine Key Stats

Sell
37
Editas Medicine (EDIT) is a Sell

Day range:
$5.41 - $5.64
52-week range:
$5.11 - $11.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.46
P/B ratio:
1.32%

Volume:
1.3M
Avg. volume:
1.7M
1-year change:
-28.59%
Market cap:
$459.8M
Revenue:
$78.1M
EPS:
$-2.05

How Much Does Editas Medicine Make?

Is Editas Medicine Growing As A Company?

  • What Is Editas Medicine's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 8.19%
  • What Is Editas Medicine's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Editas Medicine Stock Price Performance

  • Did Editas Medicine Stock Go Up Last Month?
    Editas Medicine share price went down by -18.2% last month
  • Did EDIT's Share Price Rise Over The Last Year?
    EDIT share price fell by -28.59% over the past 1 year

What Is Editas Medicine 52-Week High & Low?

Editas Medicine Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Editas Medicine?

  • How Much Debt Does Editas Medicine Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Editas Medicine Have?
    Cash and short term investments quarterly total is $323.1M
  • What Is Editas Medicine’s Book Value Per Share?
    Book value per share is 4.27

Is Editas Medicine Cash Flow Positive?

  • What Is EDIT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$132.2M
  • What Is Editas Medicine’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $118M
  • What Is Editas Medicine’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.7M

Editas Medicine Return On Invested Capital

  • Is Management Doing A Good Job?
    EDIT return on invested capital is -42.86%
  • What Is Editas Medicine Return On Assets?
    ROA measures how assets are converting to revenues and is -30.35%
  • What Is EDIT Return On Equity?
    ROE is a measure of profitability and is -42.86%

Editas Medicine Earnings Date & Stock Price

Editas Medicine Competitors

  • Who Are Editas Medicine's Competitors?
    Below is a list of companies who compete with Editas Medicine or are related in some way:
    • Amicus Therapeutics Inc (FOLD)
    • Geron Corp (GERN)
    • Moderna Inc (MRNA)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Vertex Pharmaceuticals Inc (VRTX)

Editas Medicine Dividend Yield

Data Unavailable

Editas Medicine Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 52.16%
Revenue: 818.74% 319.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 9
Sell Recommendations: 1
Price Target: 15.40
Upside from Last Price: 174.02%

Major Shareholders

  • How many EDIT shares are owned by institutional investors?
    86.5M EDIT shares are owned by institutional investors
  • How many EDIT shares are owned by insiders?
    3M EDIT shares are owned by insiders